Cardiomyocyte Foxp1‐Specific Deletion Promotes Post‐injury Heart Regeneration via Targeting Usp20‐HIF1ɑ‐Hand1 Signaling Pathway
The adult mammalian heart has limited regenerative capacity to replace lost tissue after a major injury. Forkhead box P1 (Foxp1) regulates embryonic cardiomyocyte proliferation and heart development. However, whether Foxp1 participates in postnatal-injury cardiomyocyte proliferation and heart regeneration remains unclear. This study demonstrates that Foxp1 is downregulated at border zone cardiomyocytes of both neonatal apical resection and adult myocardial infarction. Analysis of the Single-cell transcriptome database reveals reduced Foxp1 expression in the cardiomyocyte population with high regenerative capacity. Cardiomyocyte-Foxp1 loss-of-function significantly promotes, whereas cardiomyocytes-Foxp1 gain-of-function suppresses cardiomyocyte proliferation. Mechanistically, Foxp1 directly regulates ubiquitin specific peptidase 20 (USP20), a de-ubiquitinase that prevents hypoxia inducible factor 1ɑ (HIF1α) degradation. Thus, Foxp1 regulates HIF1α and downstream heart and neural crest derivatives expressed 1 (Hand1) to control the cardiomyocyte proliferation via metabolic transition from fatty acid oxidation to glycolysis. Finally, cardiac type troponin T2 (cTnT)-promoter-driven adeno-associated virus 9 (AAV9) for Hand1 induction in cardiomyocytes significantly promoted cardiac regeneration and functional recovery. These findings may provide novel molecular strategies to promote heart regeneration and therapeutic interventions for heart failure.
Authors
- Wenzhen Bao
- Tao Zhuang (ORCID: https://orcid.org/0000-0001-9139-193X)
- Paul Chan (ORCID: https://orcid.org/0000-0003-4958-5487)
- Xiaoli Chen (ORCID: https://orcid.org/0000-0001-7327-4860)
- Jie Liu (ORCID: https://orcid.org/0000-0002-9476-1833)
- Shougang Zhuang (ORCID: https://orcid.org/0000-0001-9719-4187)
- Wenrun Wu (ORCID: https://orcid.org/0000-0001-7781-406X)
- Yushi Lu (ORCID: https://orcid.org/0000-0002-0976-4213)
- Sheng Peng (ORCID: https://orcid.org/0000-0002-2497-979X)
- Brian Tomlinson (ORCID: https://orcid.org/0000-0001-6717-5444)
- Xiaoyu Wang (ORCID: https://orcid.org/0000-0002-4696-5460)
- Lin Zhang (ORCID: https://orcid.org/0000-0003-1961-7812)
- Qi Zhang (ORCID: https://orcid.org/0000-0002-6530-5927)
- Zhongmin Liu (ORCID: https://orcid.org/0000-0001-8439-2336)
- Yuzhen Zhang (ORCID: https://orcid.org/0000-0002-9570-1269)
- Haikun Wang (ORCID: https://orcid.org/0000-0002-4714-4672)
- Fang Ji (ORCID: https://orcid.org/0000-0002-0918-1173)
- Teng Xu
- Yanfang Wang
- Jie Pi (ORCID: https://orcid.org/0000-0002-9825-1398)
Institutions
- Macau University of Science and Technology (MO)
- Fudan University (CN)
- Brown University (US)
- Rhode Island Hospital (US)
- Baotou Central Hospital (CN)
- Shanghai East Hospital (CN)
- Wan Fang Hospital (TW)
- First Affiliated Hospital of Wannan Medical College (CN)
- State Key Laboratory of Cardiovascular Disease
- Taipei Medical University (TW)
Publication Details
- Journal
- Advanced Science
- Published
- 2025-02-03
- DOI
- https://doi.org/10.1002/advs.202412124
- Citations
- 6
- Primary Topic
- Congenital heart defects research
- Type
- article
- Field-Weighted Citation Impact
- 4.84
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Shanghai Rising-Star Program
- National Key Research and Development Program of China